{
  "id": 5314,
  "text": "J Clin Oncol 1999;17:1339-1348.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10334517.133.Rose PG, Bundy BN, Watkins EB, et al.Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: J Clin Oncol 1999;17:1339-1348.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10334517.133.Rose PG, Bundy BN, Watkins EB, et al.Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于局部晚期宫颈癌的治疗，目前效果较好的联合疗法主要包括以顺铂为基础的同步放化疗。这种治疗策略已被广泛验证，其主要优势在于同步使用放疗与化疗能够互相增强抗肿瘤作用，提高局部控制率并延长患者生存期。顺铂作为化疗药物在增敏放疗效果以及减少肿瘤扩散方面展现出显著作用。此联合疗法已成为治疗局部晚期宫颈癌的标准方案，并被多项临床研究与指南推荐。",
  "query": "对于局部晚期宫颈癌的治疗，哪些联合疗法被认为效果较好？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于局部晚期宫颈癌的治疗，哪些联合疗法被认为效果较好？\n\n<reference text>: J Clin Oncol 1999;17:1339-1348.Available at: http://www.ncbi.nlm.nih.gov/pubmed/10334517.133.Rose PG, Bundy BN, Watkins EB, et al.Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于局部晚期宫颈癌的治疗，目前效果较好的联合疗法主要包括以顺铂为基础的同步放化疗。这种治疗策略已被广泛验证，其主要优势在于同步使用放疗与化疗能够互相增强抗肿瘤作用，提高局部控制率并延长患者生存期。顺铂作为化疗药物在增敏放疗效果以及减少肿瘤扩散方面展现出显著作用。此联合疗法已成为治疗局部晚期宫颈癌的标准方案，并被多项临床研究与指南推荐。"
}